KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Other Non-Current Assets (2016 - 2024)

Historic Other Non-Current Assets for Astrazeneca (AZN) over the last 10 years, with Q4 2024 value amounting to $356.0 million.

  • Astrazeneca's Other Non-Current Assets rose 2992.7% to $356.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $356.0 million, marking a year-over-year increase of 2992.7%. This contributed to the annual value of $356.0 million for FY2024, which is 2992.7% up from last year.
  • Latest data reveals that Astrazeneca reported Other Non-Current Assets of $356.0 million as of Q4 2024, which was up 2992.7% from $274.0 million recorded in Q4 2023.
  • Over the past 5 years, Astrazeneca's Other Non-Current Assets peaked at $447.0 million during Q1 2021, and registered a low of $131.0 million during Q1 2020.
  • Over the past 5 years, Astrazeneca's median Other Non-Current Assets value was $356.0 million (recorded in 2024), while the average stood at $319.6 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 64493.33% in 2020, then crashed by 3785.17% in 2022.
  • Over the past 5 years, Astrazeneca's Other Non-Current Assets (Quarter) stood at $395.0 million in 2020, then decreased by 1.01% to $391.0 million in 2021, then crashed by 37.85% to $243.0 million in 2022, then rose by 12.76% to $274.0 million in 2023, then increased by 29.93% to $356.0 million in 2024.
  • Its Other Non-Current Assets stands at $356.0 million for Q4 2024, versus $274.0 million for Q4 2023 and $243.0 million for Q4 2022.